Efficacy and safety of crizotinib in patients (pts) with advanced MET exon 14-altered non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Drilon, A. E.; Camidge, D. R.; Ou, S. H. I.; Clark, J. W.; Socinski, M. A.; Weiss, J.; Riely, G. J.; Winter, M.; Wang, S. C.; Monti, K.; Wilner, K. D.; Paik, P. K. |
| Abstract Title: | Efficacy and safety of crizotinib in patients (pts) with advanced MET exon 14-altered non-small cell lung cancer (NSCLC) |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 7s |
| Language: | English |
| ACCESSION: | WOS:000404665400009 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.108 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 108 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
